The cell line development (CLD) market continues to grow and an increasing number of new CLD labs are being established around the World. The main challenge often for these groups is how, for a limited number of scientists and perhaps of limited domain experience, do they go about purchasing the right platform solution? This solution must ensure they can implement CLD quickly, cost effectively, and successfully deliver on the corporate cell line project commitments and future demands? We will present on how Solentim is uniquely positioned to help these new CLD groups
.jpg "Ian M. Taylor, Ph.D photo")